Mitochondrial donor source selection for osteoporosis therapy: functional heterogeneity and quality criteria for osteogenic efficacy
Mitochondrial failure is now viewed as an active driver of bone loss in osteoporosis, not merely a downstream consequence of aging. Defective mitochondria impair osteoblast differentiation, increase osteoclast activity, and disturb redox balance in the bone marrow niche.